Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Tasigna is the first and only second-generation tyrosine kinase inhibitor approved in the EU ...
14 New Plans Cover ThyGenX® and ThyraMIR® in 2018 to DatePARSIPPANY, N.J., May 10, ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email